(UroToday.com) Dr. Nathan Brooks, Society of Urologic Oncology (SUO) Fellow at the MD Anderson Cancer Center, Houston, Texas, USA presented “Correlation Between Body Mass Index (BMI), diabetes mellitus (DM), and Outcomes in Patients Treated with Bacillus Calmette Guerin (BCG) Immunotherapy for non-muscle-invasive bladder cancer (NMIBC).”  An ‘obesity paradox’ exists in a number of malignancies, characterized by generally poor disease-specific survival but the improved response to immunotherapy.